A novel mechanism of lentinan for the treatment of gastric cancer has been demonstrated through inhibition of programmed cell death ligand 1 (PD-L1), which binds to programmed cell death receptor 1 (PD-1) expressed on activated T lymphocytes [169]. Here, CD274 is linked to gastric cancer.